Bessemer Group Inc Edwards Lifesciences Corp Transaction History

Bessemer Group Inc

  • $60.7 Billion
  • Q3 2024

A detailed history of Bessemer Group Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bessemer Group Inc holds 395,550 shares of EW stock, worth $26.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
395,550
Previous 392,132 0.87%
Holding current value
$26.8 Million
Previous $36.2 Million 27.94%
% of portfolio
0.04%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$59.7 - $93.78 $204,054 - $320,540
3,418 Added 0.87%
395,550 $26.1 Million
Q2 2024

Aug 13, 2024
SELL
$84.3 - $94.31 $82,782 - $92,612
-982 Reduced 0.25%
392,132 $36.2 Million
Q1 2024

May 13, 2024
SELL
$72.54 - $95.56 $2.87 Million - $3.79 Million
-39,624 Reduced 9.16%
393,114 $37.6 Million
Q4 2023

Feb 09, 2024
SELL
$61.71 - $77.76 $190,622 - $240,200
-3,089 Reduced 0.71%
432,738 $33 Million
Q3 2023

Nov 13, 2023
BUY
$69.28 - $93.38 $1.23 Million - $1.65 Million
17,719 Added 4.24%
435,827 $30.2 Million
Q2 2023

Aug 10, 2023
SELL
$81.41 - $94.33 $17.4 Million - $20.2 Million
-213,635 Reduced 33.82%
418,108 $39.4 Million
Q1 2023

May 10, 2023
SELL
$74.26 - $84.51 $4.5 Million - $5.12 Million
-60,569 Reduced 8.75%
631,743 $52.3 Million
Q4 2022

Feb 13, 2023
SELL
$68.3 - $87.44 $11.4 Million - $14.6 Million
-166,732 Reduced 19.41%
692,312 $51.7 Million
Q3 2022

Nov 09, 2022
SELL
$82.37 - $107.29 $2.4 Million - $3.13 Million
-29,154 Reduced 3.28%
859,044 $71 Million
Q2 2022

Aug 10, 2022
SELL
$86.5 - $128.27 $16.1 Million - $23.9 Million
-186,260 Reduced 17.34%
888,198 $84.5 Million
Q1 2022

May 12, 2022
SELL
$101.96 - $128.34 $10.3 Million - $13 Million
-101,388 Reduced 8.62%
1,074,458 $126 Million
Q4 2021

Jan 27, 2022
BUY
$106.37 - $130.68 $859,895 - $1.06 Million
8,084 Added 0.69%
1,175,846 $152 Million
Q3 2021

Nov 12, 2021
BUY
$102.91 - $122.75 $33,548 - $40,016
326 Added 0.03%
1,167,762 $132 Million
Q2 2021

Aug 06, 2021
BUY
$83.84 - $104.76 $8.88 Million - $11.1 Million
105,947 Added 9.98%
1,167,436 $121 Million
Q1 2021

May 13, 2021
BUY
$78.68 - $90.67 $16.5 Million - $19 Million
209,381 Added 24.57%
1,061,489 $88.8 Million
Q4 2020

Feb 09, 2021
SELL
$71.69 - $91.23 $71,976 - $91,594
-1,004 Reduced 0.12%
852,108 $77.7 Million
Q3 2020

Nov 12, 2020
BUY
$67.19 - $87.44 $9.42 Million - $12.3 Million
140,177 Added 19.66%
853,112 $68.1 Million
Q2 2020

Aug 05, 2020
BUY
$57.54 - $76.95 $26.6 Million - $35.5 Million
461,981 Added 184.09%
712,935 $49.3 Million
Q1 2020

Apr 30, 2020
SELL
$52.41 - $81.0 $3.11 Million - $4.81 Million
-59,321 Reduced 19.12%
250,954 $47.3 Million
Q4 2019

Feb 04, 2020
SELL
$71.7 - $82.09 $11.7 Million - $13.4 Million
-163,080 Reduced 34.45%
310,275 $72.4 Million
Q3 2019

Nov 07, 2019
SELL
$61.55 - $75.43 $1.86 Million - $2.29 Million
-30,297 Reduced 6.02%
473,355 $104 Million
Q2 2019

Jul 19, 2019
BUY
$55.74 - $64.41 $28 Million - $32.4 Million
502,759 Added 56300.0%
503,652 $93 Million
Q1 2019

May 13, 2019
BUY
$47.89 - $64.05 $22,364 - $29,911
467 Added 109.62%
893 $172,000
Q4 2018

Feb 12, 2019
BUY
$46.41 - $56.94 $6,450 - $7,914
139 Added 48.43%
426 $65,000
Q3 2018

Nov 06, 2018
BUY
$45.7 - $58.03 $12,339 - $15,668
270 Added 1588.24%
287 $50,000
Q1 2018

May 10, 2018
BUY
$37.19 - $47.45 $632 - $806
17 New
17 $2,000
Q4 2017

Jan 30, 2018
SELL
$33.79 - $39.39 $1,351 - $1,575
-40 Closed
0 $0
Q3 2017

Nov 03, 2017
BUY
$36.29 - $38.83 $1,451 - $1,553
40
40 $4,000

Others Institutions Holding EW

# of Institutions
1,351
Shares Held
455M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email